Correction: Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients

Affiliations

• ¹ Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
• ² Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
• ³ Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA.
• ⁴ Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
• ⁵ Department of BioHealth Informatics, Indiana University-Purdue University, Indianapolis, IN, USA.
• ⁶ Alliance Statistics and Data Center, Duke University, Durham, NC, USA.
• ⁷ Levine Cancer Institute, Charlotte, NC, USA.
• ⁸ College of Pharmacy, University of Michigan, Ann Arbor, MI, USA.
• ⁹ Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
• ¹⁰ Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, USA.
• ¹¹ Dana Farber Cancer Institute, Boston, MA, USA.
• ¹² Department of Medicine, Hematology/Oncology, University of California at San Francisco, San Francisco, CA, USA.
• ¹³ University of Chicago Comprehensive Cancer Center, Chicago, IL, USA.
• ¹⁴ Department of Medical Oncology, Yale School of Medicine, New Haven, CT, USA.
• ¹⁵ Department of Bioengineering and Therapeutic Sciences, University of California at San Francisco, San Francisco, CA, USA.
• ¹⁶ Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC, USA.
• ¹⁷ Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. innocent@email.unc.edu.